Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LAG3 ELISA Kit

LAG3 Reactivity: Human Colorimetric Sandwich ELISA 0.15-10 ng/mL
Catalog No. ABIN2043901
  • Target See all LAG3 ELISA Kits
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Reactivity
    • 7
    • 4
    • 1
    Human
    Detection Method
    Colorimetric
    Method Type
    Sandwich ELISA
    Detection Range
    0.15-10 ng/mL
    Minimum Detection Limit
    0.15 ng/mL
    Application
    ELISA
    Brand
    BioAssay™
    Sensitivity
    < 0.063 ng/mL
    Featured
    Discover our best selling LAG3 ELISA Kit
    Top Product
    Discover our top product LAG3 ELISA Kit
  • Plate
    Pre-coated
    Protocol
    Lymphocyte Activation Gene 3 (LAG3) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Lymphocyte Activation Gene 3 (LAG3). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Lymphocyte Activation Gene 3 (LAG3). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Lymphocyte Activation Gene 3 (LAG3), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Lymphocyte Activation Gene 3 (LAG3) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
    Restrictions
    For Research Use only
  • Storage
    4 °C/-20 °C
  • Target See all LAG3 ELISA Kits
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Alternative Name
    Lymphocyte Activation Gene 3 (LAG3) (LAG3 Products)
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Support